If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> DERMATOLOGY<br /> EMJ Dermatol. 2017 Suppl 2 • europeanmedical-journal.com<br /> INSIDE<br /> Chronic Venous Insufficiency:<br /> Management and Treatment<br /> CHRONIC VENOUS INSUFFICIENCY:<br /> MANAGEMENT AND TREATMENT<br /> Summary of selected presentations from the<br /> Chronic Venous Disease and Haemorrhoidal Disease:<br /> Their Management and Treatment MASTERCLASS held<br /> in Lisbon, Portugal, from 23rd–24th September 2016<br /> Speakers<br /> Kursat Bozkurt,1 Eberhard Rabe,2 Mohamed I. Sharkawy3<br /> 1. Professor of Cardiovascular Surgery, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey<br /> 2. Professor of Dermatology, Phlebological Department in the Department of Dermatology,<br /> University of Bonn, Bonn, Germany<br /> 3. Professor of Vascular Surgery and Peripheral Endovascular Intervention,<br /> <a title="EMJ Dermatol. 2017 Suppl 2 page 1" href="http://viewer.zmags.com/publication/a1b299f9?page=1"> DERMATOLOGY EMJ Dermatol. 2017 Suppl 2 • european</a> <a title="EMJ Dermatol. 2017 Suppl 2 page 2" href="http://viewer.zmags.com/publication/a1b299f9?page=2"> CHRONIC VENOUS INSUFFICIENCY: MANAGEMENT AND TR</a> <a title="EMJ Dermatol. 2017 Suppl 2 page 3" href="http://viewer.zmags.com/publication/a1b299f9?page=3"> Table 1: Revised Clinical Etiologic Anatomic Path</a> <a title="EMJ Dermatol. 2017 Suppl 2 page 4" href="http://viewer.zmags.com/publication/a1b299f9?page=4"> are exacerbated by muscle-pump dysfunction or</a> <a title="EMJ Dermatol. 2017 Suppl 2 page 5" href="http://viewer.zmags.com/publication/a1b299f9?page=5"> In cases of deep abdominal or pelvic veins which </a> <a title="EMJ Dermatol. 2017 Suppl 2 page 6" href="http://viewer.zmags.com/publication/a1b299f9?page=6"> from plant extracts (Table 2). Their evidence bas</a> <a title="EMJ Dermatol. 2017 Suppl 2 page 7" href="http://viewer.zmags.com/publication/a1b299f9?page=7"> Data indicate that the use of venoactive drugs is</a> <a title="EMJ Dermatol. 2017 Suppl 2 page 8" href="http://viewer.zmags.com/publication/a1b299f9?page=8"> Stage C4, or CVI duration >12 years) a 77</a> <a title="EMJ Dermatol. 2017 Suppl 2 page 9" href="http://viewer.zmags.com/publication/a1b299f9?page=9"> The primary endpoint of relative volume change in</a> <a title="EMJ Dermatol. 2017 Suppl 2 page 10" href="http://viewer.zmags.com/publication/a1b299f9?page=10"> 600 500 400 300 Number of patients 200 100 </a> <a title="EMJ Dermatol. 2017 Suppl 2 page 11" href="http://viewer.zmags.com/publication/a1b299f9?page=11"> patients referred for amputation. Cases involving</a> <a title="EMJ Dermatol. 2017 Suppl 2 page 12" href="http://viewer.zmags.com/publication/a1b299f9?page=12"> inflammation in the microcirculature a</a> <a title="EMJ Dermatol. 2017 Suppl 2 page 13" href="http://viewer.zmags.com/publication/a1b299f9?page=13"> Vasa. 2008;37(3):233-40. 30. Brunet J et al. In v</a>